Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review

Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that is engaged in discovery, development, licensing and manufacturing, marketing, distribution and sale of medicines and related medical products to patients with serious diseases. Its primary focus is on cancer, immunology, cardiovascular, and fibrotic therapeutic projects. The company offers its products across the world to wholesalers, retail pharmacies, medical professionals, hospitals and government entities. BMS provides its products in the US, Europe, and Japan. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in Princeton, New Jersey, the US.

Bristol-Myers Squibb Co Key Recent Developments

Apr 25,2024: Bristol Myers Squibb Reports First Quarter Financial Results for 2024
Apr 22,2024: Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
Feb 27,2024: Bristol Myers Squibb acquires RayzeBio for $4.1bn
Feb 22,2024: Immunocore and BMS partner to investigate first-line treatment for melanoma

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Bristol-Myers Squibb Co - Key Facts
Bristol-Myers Squibb Co - Key Employees
Bristol-Myers Squibb Co - Key Employee Biographies
Bristol-Myers Squibb Co - Major Products and Services
Bristol-Myers Squibb Co - History
Bristol-Myers Squibb Co - Company Statement
Bristol-Myers Squibb Co - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Bristol-Myers Squibb Co - Business Description
Other Break-up: In-Line Products
Performance
Other Break-up: New Product Portfolio
Performance
Other Break-up: Recent LOE Products
Performance
Geographical Segment: International,Other,Rest of the World
Performance
Geographical Segment: United States
Performance
R&D Overview
Bristol-Myers Squibb Co - Corporate Strategy
Bristol-Myers Squibb Co - SWOT Analysis
SWOT Analysis - Overview
Bristol-Myers Squibb Co - Strengths
Bristol-Myers Squibb Co - Weaknesses
Bristol-Myers Squibb Co - Opportunities
Bristol-Myers Squibb Co - Threats
Bristol-Myers Squibb Co - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Bristol-Myers Squibb Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 25, 2024: Bristol Myers Squibb Reports First Quarter Financial Results for 2024
Apr 22, 2024: Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
Feb 27, 2024: Bristol Myers Squibb acquires RayzeBio for $4.1bn
Feb 22, 2024: Immunocore and BMS partner to investigate first-line treatment for melanoma
Feb 02, 2024: Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
Jan 24, 2024: New Anti-Blood Clotting Drug May Lower Risk of Recurrent Strokes
Jan 05, 2024: Sosei Group Announces Appointment of Experienced Pharmaceutical Executive Toshihiro Maeda as Chief Operating Officer
Jan 04, 2024: The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk
Jan 01, 2024: BMS Group appoints Andras Bohm as head of U.S. Capital Advisory
Jan 01, 2024: BMS Group appoints Tim Hewitt as head of Japan
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Bristol-Myers Squibb Co, Key Facts
Bristol-Myers Squibb Co, Key Employees
Bristol-Myers Squibb Co, Key Employee Biographies
Bristol-Myers Squibb Co, Major Products and Services
Bristol-Myers Squibb Co, History
Bristol-Myers Squibb Co, Subsidiaries
Bristol-Myers Squibb Co, Joint Venture
Bristol-Myers Squibb Co, Key Competitors
Bristol-Myers Squibb Co, Ratios based on current share price
Bristol-Myers Squibb Co, Annual Ratios
Bristol-Myers Squibb Co, Annual Ratios (Cont...1)
Bristol-Myers Squibb Co, Annual Ratios (Cont...2)
Bristol-Myers Squibb Co, Interim Ratios
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Bristol-Myers Squibb Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Bristol-Myers Squibb Co, Performance Chart (2019 - 2023)
Bristol-Myers Squibb Co, Ratio Charts
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Bristol-Myers Squibb Co, Pharmaceuticals & Health

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings